2009 Santa Fe Bone Symposium

Abstract Osteoporosis is a common skeletal disease with serious clinical consequences because of fractures. Despite the availability of clinical tools to diagnose osteoporosis and assess fracture risk, and drugs proven to reduce fracture risk, it remains a disease that is underdiagnosed and undertre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical densitometry 2010, Vol.13 (1), p.1-9
Hauptverfasser:	Lewiecki, E. Michael, Bilezikian, John P, Laster, Andrew J, Miller, Paul D, Recker, Robert R, Russell, R. Graham G, Whyte, Michael P
Format:	Artikel
Sprache:	eng
Schlagworte:	Bisphosphonates Bone Density Conservation Agents - therapeutic use Bone Remodeling - drug effects Congresses as Topic denosumab emerging therapy Endocrinology & Metabolism Fractures, Bone - etiology Fractures, Bone - prevention & control histomorphometry Humans New Mexico odanacatib osteoporosis Osteoporosis - complications Osteoporosis - drug therapy treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!